Home
NerPharma Srl

NerPharma Srl Market Share Analysis for May 2026

NerPharMa is CDMO and operates as a drug development and manufacturing organization with a strong expertise in oncology

Industry: N/A

Domainnerpharma.com

Year Founded--

Employees51 - 200

Annual Revenue$15M - $25M

NerPharma Srl

NerPharma Srl (including company regionals)

nerpharma.com

See more website traffic and engagement information

NerPharma Srl Revenue up to May 2026 is 15M - 25M

revenue generated by NerPharma Srl top domains

NerPharma Srl top domains revenue over 3 years

Revenue for NerPharma Srl top domains

nerpharma.com15M - 25M

See more with Sales Intelligence

Total visits to NerPharma Srl's top domains

Understand NerPharma Srl market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nerpharma.com785

See more with Sales Intelligence

Avg. visit duration in NerPharma Srl's top domains

Analyze NerPharma Srl engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nerpharma.com00:00:30

See more with Sales Intelligence

Avg. pageviews on NerPharma Srl's top domains

See how NerPharma Srl keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nerpharma.com1.91

See more with Sales Intelligence

NerPharma Srl top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by NerPharma Srl

These are the website technologies, by industry, used by NerPharma Srl top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

Content Management System (1)

WordPress

More Technologies

7

See all

News & Signals from NerPharma Srl

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBenta Group acquired NerPharMa - A Company of NMS Group on Feb 18th '26.Milan, Italy, 18 February 2026 Benta has announced the acquisition of NerPharMa, a pharmaceutical manufacturing company located in Milan, Italy, from NMS Group.

NewsNerPharMa - A Company of NMS Group hired Serena Alvino as Chief Executive Officer on Jul 28th '25.NERVIANO, Italy, 28 July 2025 - NerPharMa (NPM), a renowned Contract Development and Manufacturing Organization (CDMO) specializing in oncology and in immunology, today announced the appointment of Serena Alvino, MBA, CIPP/E, as its new Chief Executive Officer, effective immediately.

NewsNerPharMa - A Company of NMS Group hires Vittorio Montanaro as industrial operations Site Head and member of Board of Directors.NerPharMa appoints Vittorio Montanaro as new industrial operations Site Head and member of Board of Directors to fortify its commitment to excellence.